Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 154,449 | reported | 06 Mar 2026 | tx 9+266,609−60,165 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 8,069 | 14.32 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 40,586 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 67,870 | 0.00 USD | deriv |
| 02 Feb 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 11,552 | 14.53 USD | |
| 01 Aug 2025 | SALE | Aurinia Pharmaceuticals Inc. | 20,000 | 10.50 USD | |
| 07 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 8,305 | 8.23 USD | |
| 03 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 12,239 | 8.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 62,583 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 95,570 | 0.00 USD | deriv |